Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clarus Ventures names two new partners

This article was originally published in Scrip

Executive Summary

Clarus Ventures, a US life sciences venture capital firm, has promoted Dr Emmett Cunninghamto partner and Scott Requadt to transactional partner. Dr Cunningham joined Clarus in 2006 and represents the firm as a director on the board of SARcode and as a board observer at FerroKin, Pearl, Taligen and Zogenix. Mr Requadt joined Clarus in 2005 and represents the firm as a director on the board of TyRx Pharma and as a board observer at Biolex, Oxford Immunotec, Link Medicine and Variation.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC008074

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel